GSTA1/CTNNB1 axis facilitates sorafenib resistance via suppressing ferroptosis in hepatocellular carcinoma
The emergence of sorafenib resistance has become a predominant impediment and formidable dilemma in the therapeutic approach for hepatocellular carcinoma (HCC). Although the approval of next-generation drugs as alternatives to sorafenib is a significant development, the concurrent use of inhibitors...
Saved in:
Main Authors: | Shiwen Ma (Author), Fei Xie (Author), Xiaohu Wen (Author), Yao Mawulikplimi Adzavon (Author), Ruping Zhao (Author), Jinyi Zhao (Author), Han Li (Author), Yanqi Li (Author), Jingtao Liu (Author), Chen Liu (Author), Yang Yi (Author), Pengxiang Zhao (Author), Boqing Wang (Author), Wei Zhao (Author), Xuemei Ma (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2024-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
ATF3 promotes ferroptosis in sorafenib-induced cardiotoxicity by suppressing Slc7a11 expression
by: Yilan Li, et al.
Published: (2022) -
Dihydroartemisinin enhances the inhibitory effect of sorafenib on HepG2 cells by inducing ferroptosis and inhibiting energy metabolism
by: Zhao Cui, et al.
Published: (2022) -
Ferroptosis resistance in cancer cells: nanoparticles for combination therapy as a solution
by: Kodzo Prosper Adzavon, et al.
Published: (2024) -
Mechanism of sorafenib resistance associated with ferroptosis in HCC
by: Lingling Guo, et al.
Published: (2023) -
LncRNA DACH1 protects against pulmonary fibrosis by binding to SRSF1 to suppress CTNNB1 accumulation
by: Jian Sun, et al.
Published: (2022)